Literature DB >> 32791949

Antiplatelet Therapy Following Peripheral Arterial Interventions: The Choice Is Yours.

Aaron W Aday1, J Antonio Gutierrez2.   

Abstract

Entities:  

Keywords:  Editorials; aspirin; clopidogrel; myocardial infarction; peripheral artery disease; population

Year:  2020        PMID： 32791949      PMCID： PMC7593982          DOI： 10.1161/CIRCINTERVENTIONS.120.009727

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  10 in total

Review 1.  A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.

Authors:  Connie N Hess; Lars Norgren; Gary M Ansel; Warren H Capell; John P Fletcher; F Gerry R Fowkes; Anders Gottsäter; Kerry Hitos; Michael R Jaff; Joakim Nordanstig; William R Hiatt
Journal:  Circulation       Date:  2017-06-20       Impact factor: 29.690

2.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).

Authors:  Victor Aboyans; Jean-Baptiste Ricco; Marie-Louise E L Bartelink; Martin Björck; Marianne Brodmann; Tina Cohnert; Jean-Philippe Collet; Martin Czerny; Marco De Carlo; Sebastian Debus; Christine Espinola-Klein; Thomas Kahan; Serge Kownator; Lucia Mazzolai; A Ross Naylor; Marco Roffi; Joachim Röther; Muriel Sprynger; Michal Tendera; Gunnar Tepe; Maarit Venermo; Charalambos Vlachopoulos; Ileana Desormais
Journal:  Eur Heart J       Date:  2018-03-01       Impact factor: 29.983

Review 3.  Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.

Authors:  Henri M H Spronk; Anne Margreet de Jong; Harry J Crijns; Ulrich Schotten; Isabelle C Van Gelder; Hugo Ten Cate
Journal:  Cardiovasc Res       Date:  2014-01-02       Impact factor: 10.787

4.  Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease.

Authors:  Frederik F Strobl; Klaus Brechtel; Jörg Schmehl; Thomas Zeller; Maximilian F Reiser; Claus D Claussen; Gunnar Tepe
Journal:  J Endovasc Ther       Date:  2013-10       Impact factor: 3.487

5.  Patients with peripheral arterial disease in the CHARISMA trial.

Authors:  Patrice P Cacoub; Deepak L Bhatt; P Gabriel Steg; Eric J Topol; Mark A Creager
Journal:  Eur Heart J       Date:  2009-01-09       Impact factor: 29.983

6.  Rivaroxaban in Peripheral Artery Disease after Revascularization.

Authors:  Marc P Bonaca; Rupert M Bauersachs; Sonia S Anand; E Sebastian Debus; Mark R Nehler; Manesh R Patel; Fabrizio Fanelli; Warren H Capell; Lihong Diao; Nicole Jaeger; Connie N Hess; Akos F Pap; John M Kittelson; Ivan Gudz; Lajos Mátyás; Dainis K Krievins; Rafael Diaz; Marianne Brodmann; Eva Muehlhofer; Lloyd P Haskell; Scott D Berkowitz; William R Hiatt
Journal:  N Engl J Med       Date:  2020-03-28       Impact factor: 91.245

7.  Discharge Prescription Patterns for Antiplatelet Therapy Following Lower Extremity Peripheral Vascular Intervention.

Authors:  Nikhil Singh; Li Ding; Gregory A Magee; David M Shavelle; Vikram S Kashyap; Parveen K Garg
Journal:  Circ Cardiovasc Interv       Date:  2020-08-14       Impact factor: 6.546

8.  Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia.

Authors:  Navneet Narula; Andrew J Dannenberg; Jeffrey W Olin; Deepak L Bhatt; Kipp W Johnson; Girish Nadkarni; James Min; Sho Torii; Priti Poojary; Sonia S Anand; Jeroen J Bax; Salim Yusuf; Renu Virmani; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2018-08-27       Impact factor: 24.094

9.  Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.

Authors:  Marc P Bonaca; Deepak L Bhatt; Robert F Storey; Ph Gabriel Steg; Marc Cohen; Julia Kuder; Erica Goodrich; José C Nicolau; Alexander Parkhomenko; José López-Sendón; Mikael Dellborg; Anthony Dalby; Jindřich Špinar; Philip Aylward; Ramón Corbalán; Maria Teresa B Abola; Eva C Jensen; Peter Held; Eugene Braunwald; Marc S Sabatine
Journal:  J Am Coll Cardiol       Date:  2016-04-01       Impact factor: 24.094

Review 10.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.